Ortiz P A, Garvin J L
Division of Hypertension and Vascular Research, Henry Ford Hospital, Detroit, Michigan, USA.
Hypertension. 2001 Feb;37(2 Pt 2):467-71. doi: 10.1161/01.hyp.37.2.467.
In the isolated, perfused rat thick ascending limb (THAL), L-arginine (L-Arg) stimulates endogenous nitric oxide (NO) production, which inhibits NaCl absorption. However, the intracellular cascade responsible for the effects of NO has not been studied. We hypothesized that endogenous NO inhibits THAL NaCl transport by increasing cGMP, which activates protein kinase G (PKG) and cGMP-stimulated phosphodiesterase (PDE II), which, in turn, decreases cAMP levels. THALs from rats were isolated and perfused, and net chloride flux (J(Cl-)) was measured. L-Arg was used to stimulate NO production. Adding L-Arg (0.5 mmol/L) to the bath decreased J(Cl-) from 154.4+/-9.9 to 101.9+/-14.1 pmol. mm(-1). min(-1), a 35.2% decrease (n=6; P<0.05). In the presence of the soluble guanylate cyclase inhibitor LY-83583 (10 micromol/L), adding L-Arg to the bath did not affect THAL J(Cl-) (143.7+/-28.1 versus 136.7+/-22.2 pmol. mm(-1). min(-1); n=6). LY-83583 alone had no effect on J(Cl-). In the presence of the PDE II inhibitor erythro-9-(2-hydroxy-3-nonyl) adenine (EHNA) 50 micromol/L, L-Arg reduced J(Cl-) by only 13% (142.1+/-8.9 versus 122.7+/-11.5 pmol. mm(-1). min(-1); P<0.05; n=6). EHNA alone had no effect on THAL J(Cl-). In the presence of 10(-5) mol/L dibutyryl (db)-cAMP, L-Arg did not significantly reduce J(Cl-) (116.3+/-18.2 versus 102.6+/-15.6 pmol. mm(-1). min(-1); n=6). db-cAMP (10(-5) mol/L) had no effect on THAL J(Cl-). In the presence of the PKG inhibitor KT-5823 (2 micromol/L), L-Arg lowered J(Cl-) from 142.6+/-14.1 to 85.9+/-8.3 pmol. mm(-1). min(-1), a decrease of 35.6% (n=8; P<0.05). We conclude that (1) endogenous NO inhibits THAL J(Cl-) by stimulating soluble guanylate cyclase and increasing cGMP; (2) NO inhibits THAL J(Cl-) by stimulation of PDE II, which, in turn, decreases cAMP levels; and (3) PKG does not mediate NO-induced inhibition of THAL J(Cl-).
在分离灌注的大鼠厚升支(THAL)中,L-精氨酸(L-Arg)刺激内源性一氧化氮(NO)生成,而NO会抑制氯化钠的重吸收。然而,负责NO作用的细胞内级联反应尚未得到研究。我们推测内源性NO通过增加环磷酸鸟苷(cGMP)来抑制THAL对氯化钠的转运,cGMP可激活蛋白激酶G(PKG)和cGMP刺激的磷酸二酯酶(PDE II),进而降低环磷酸腺苷(cAMP)水平。分离并灌注大鼠的THAL,测量净氯通量(J(Cl-))。使用L-Arg刺激NO生成。向浴槽中添加L-Arg(0.5 mmol/L)可使J(Cl-)从154.4±9.9降至101.9±14.1 pmol·mm⁻¹·min⁻¹,降低了35.2%(n = 6;P<0.05)。在存在可溶性鸟苷酸环化酶抑制剂LY-83583(10 μmol/L)的情况下,向浴槽中添加L-Arg对THAL的J(Cl-)没有影响(143.7±28.1与136.7±22.2 pmol·mm⁻¹·min⁻¹;n = 6)。单独使用LY-83583对J(Cl-)没有影响。在存在PDE II抑制剂赤藓红-9-(2-羟基-3-壬基)腺嘌呤(EHNA)50 μmol/L的情况下,L-Arg仅使J(Cl-)降低了13%(142.1±8.9与122.7±11.5 pmol·mm⁻¹·min⁻¹;P<0.05;n = 6)。单独使用EHNA对THAL的J(Cl-)没有影响。在存在10⁻⁵ mol/L二丁酰(db)-cAMP的情况下,L-Arg没有显著降低J(Cl-)(116.3±18.2与102.6±15.6 pmol·mm⁻¹·min⁻¹;n = 6)。db-cAMP(10⁻⁵ mol/L)对THAL的J(Cl-)没有影响。在存在PKG抑制剂KT-5823(2 μmol/L)的情况下,L-Arg使J(Cl-)从142.6±14.1降至85.9±8.3 pmol·mm⁻¹·min⁻¹,降低了35.6%(n = 8;P<0.05)。我们得出结论:(1)内源性NO通过刺激可溶性鸟苷酸环化酶并增加cGMP来抑制THAL的J(Cl-);(2)NO通过刺激PDE II来抑制THAL的J(Cl-),进而降低cAMP水平;(3)PKG不介导NO诱导的对THAL的J(Cl-)的抑制作用。